Pharmacologic Stabilization and Management of Acute Heart Failure Syndromes in the Emergency Department

James D Kirk, John T. Parissis, Gerasimos Filippatos

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Effective use of diuretics, vasodilators, and inotropes to stabilize acute heart failure (AHF) relies on matching the most appropriately tailored therapy to specific clinical profiles. Some of the drugs may be harmful, and therefore the emphasis should be on patient safety and the attempt to minimize the deleterious effects of these therapies. To date, successful treatment has been limited because no agent has been shown to reduce postdischarge mortality or readmission rates, and patients frequently remain symptomatic after treatment. Ongoing research is needed to further examine these agents and to develop novel therapies to address the unmet needs of the patient who has AHF.

Original languageEnglish (US)
Pages (from-to)43-54
Number of pages12
JournalHeart Failure Clinics
Volume5
Issue number1
DOIs
StatePublished - Jan 2009

Keywords

  • Emergency department
  • Heart failure
  • Therapeutic options

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pharmacologic Stabilization and Management of Acute Heart Failure Syndromes in the Emergency Department'. Together they form a unique fingerprint.

  • Cite this